Related to Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing

• Illumina Acquires Epicentre to Own Sequencing Library Preparation Technology
  
• Eurofins Wins Contract to Supply U.K. Research Councils with DNA Sequencing Services
  
• Erasmus University Claims Ingenuity’s IPA Software Maximizes Potential of NGS Data
  
• Cerep to Close French HQ, Cut Jobs, and Move Home Operations to Poitiers Lab Site
  
• Ingenix Sells i3 Clinical Trials Businesses and Sets Up Life Science Unit
  
• PerkinElmer Steps into DNA Sequencing Market
  
• Seven New York Research Hospitals Join Pfizer’s Centers for Therapeutic Innovation
  
• NuGEN Ovation® Prokaryotic RNA-Seq Technology Penetrates Academic Market
  
• NuGEN and Caliper Couple Solutions to Automate NGS Sample Prep
  
• Sigma Life Science and Cofactor Genomics to Sequence Six Rat Genomes
  
• Genomic Health Reports Use of Illumina NGS Technology on Archived Tumors for Biomarker Discovery
  
• Life Tech to Offer Partek Genomics Suite for Analyzing Next-Gen Sequencing Data
  
• Swedish Cancer Drug Firm Kancera Acquires Stockholm-Based CRO iNovacia
  
• PPD to Act as Primary Service Provider for Elan’s Development Pipeline
  
• Covance and Ingenuity Systems Band Together to Improve NGS Data Analysis
  
• Caliper and Covaris Ally to Simplify Sample Prep for Next-Generation Sequencing
  
• Thermo Fisher Sells Athena Diagnostics and Lancaster Labs to Quest and Eurofins for $940M
  
• NovAlix to Perform Drug Discovery Services for Janssen-Cilag
  
• Ricerca and Fulcrum Pharma Combine R&D Service Expertise
  
• Geospiza and NuGEN to Combine Technologies for Next-Gen Sequencing Sample Prep Workflow